These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 3043913)

  • 21. Disease-modifying immunotherapy for the management of autoimmune diabetes.
    Castro CN; Barcala Tabarrozi AE; Noguerol MA; Liberman AC; Dewey RA; Arzt E; Morelli AE; Perone MJ
    Neuroimmunomodulation; 2010; 17(3):173-6. PubMed ID: 20134195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Type I insulin dependent diabetes: an autoimmune disease that can be arrested or prevented with immunotherapy?
    Winter WE; Maclaren NK
    Adv Pediatr; 1985; 32():159-75. PubMed ID: 3909773
    [No Abstract]   [Full Text] [Related]  

  • 23. Relation between cellular and humoral immunity to islet cell antigens in type 1 diabetes.
    Hummel M; Durinovic-Bello I; Ziegler AG
    J Autoimmun; 1996 Jun; 9(3):427-30. PubMed ID: 8816982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of type 1 diabetics by transplantation of isolated pancreatic islets].
    Ono J
    Rinsho Byori; 2006 Apr; 54(4):379-85. PubMed ID: 16722457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunopathological and genetic features in slowly progressive insulin-dependent diabetes mellitus and latent autoimmune diabetes in adults.
    Kobayashi T; Tanaka S; Harii N; Aida K; Shimura H; Ohmori M; Kanesige M; Shimada A; Maruyama T
    Ann N Y Acad Sci; 2006 Oct; 1079():60-6. PubMed ID: 17130533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Achieving antigen-specific tolerance in diabetes: regulating specifically.
    Chen W; Bluestone JA; Herold KC
    Int Rev Immunol; 2005; 24(5-6):287-305. PubMed ID: 16318983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stem cell-based approaches to solving the problem of tissue supply for islet transplantation in type 1 diabetes.
    Street CN; Sipione S; Helms L; Binette T; Rajotte RV; Bleackley RC; Korbutt GS
    Int J Biochem Cell Biol; 2004 Apr; 36(4):667-83. PubMed ID: 15010331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of glucose transporter-2 precedes insulin loss in the nonobese diabetic and the low-dose streptozotocin mouse models: a comparative immunohistochemical study by light and confocal microscopy.
    Reddy S; Young M; Poole CA; Ross JM
    Gen Comp Endocrinol; 1998 Jul; 111(1):9-19. PubMed ID: 9653017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is insulin-dependent diabetes mellitus a preventable disease?
    Maclaren NK; Riley WJ; Winter WE; Silverstein JH
    Clin Invest Med; 1987 Sep; 10(5):444-9. PubMed ID: 3315366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Restoration of self-tolerance is a feasible approach to control ongoing beta-cell specific autoreactivity: its relevance for treatment in established diabetes and islet transplantation.
    Chatenoud L
    Diabetologia; 2001 May; 44(5):521-36. PubMed ID: 11380070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoreactivity to a 64,000 Mr human islet cell antigen in sera from insulin-dependent diabetes mellitus patients and individuals with abnormal glucose tolerance.
    Baekkeskov S
    Mol Biol Med; 1986 Apr; 3(2):137-42. PubMed ID: 3526081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes.
    Vija L; Farge D; Gautier JF; Vexiau P; Dumitrache C; Bourgarit A; Verrecchia F; Larghero J
    Diabetes Metab; 2009 Apr; 35(2):85-93. PubMed ID: 19230736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new type of CD4+ suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice.
    Han HS; Jun HS; Utsugi T; Yoon JW
    J Autoimmun; 1996 Jun; 9(3):331-9. PubMed ID: 8816968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospects for gene therapy of insulin-dependent diabetes mellitus.
    Efrat S
    Diabetologia; 1998 Dec; 41(12):1401-9. PubMed ID: 9867206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunotherapy for the prevention and treatment of type 1 diabetes.
    Goudy KS; Tisch R
    Int Rev Immunol; 2005; 24(5-6):307-26. PubMed ID: 16318984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoimmunity to islet cells in diabetes mellitus.
    Powers AC; Eisenbarth GS
    Annu Rev Med; 1985; 36():533-44. PubMed ID: 3888064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunotherapy of type 1 diabetes].
    Timsit J; Boitard C; Bach JF
    Rev Prat; 1992 May; 42(9):1075-9. PubMed ID: 1496232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The epidemiology of diabetes mellitus].
    Pérez-Comas A
    Bol Asoc Med P R; 1991 Nov; 83(11):489-95. PubMed ID: 1811596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune intervention for type 1 diabetes mellitus.
    Skyler JS
    Int J Clin Pract Suppl; 2011 Feb; (170):61-70. PubMed ID: 21323814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunopathogenesis and immunotherapeutic approaches to type 1A diabetes.
    Azam A; Eisenbarth GS
    Expert Opin Biol Ther; 2004 Oct; 4(10):1569-75. PubMed ID: 15461568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.